Akari Therapeutics Plc (AKTX)
5.14
+1.71
(+49.85%)
USD |
NASDAQ |
May 21, 16:00
11.75
+6.61
(+128.60%)
After-Hours: 19:59
Akari Therapeutics Research and Development Expense (TTM) : 3.464M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DBV Technologies SA | 119.79M |
| Cellectis SA | 80.74M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 19.05M |
| Autolus Therapeutics Plc | 112.24M |